The ALLG is an Australian not-for-profit, public unlisted company limited by guarantee and is a registered charity.

ALLG Board of Management

The ALLG is governed on behalf of members by a Board of Management in accordance with the ALLG Constitution. Subject to the exercise by the Board of the powers contained in the ALLG Constitution, the Board manages the company and directs the affairs of the company. Current Board members are:

Peter T. Kempen

AM, FCA, FAICD
Chairman of the Board

Peter was appointed to the Board as a Director and Chairman in early 2010. He is a member of the Finance and Audit Committee of the Board.

Professor

Judith Trotman

BHB, MBChB, FRACP, FRCPA, PostGrad Cert Clin Res (Oncology)
Director

Judith has been a prominent ALLG Member for more then 20 years and was a Scientific Advisory Committee (SAC) representative member from 2014 – 2019. She was appointed as the Chair of the SAC in October 2022.

Geraldine Gray

BA, LLB, LLM
Director

Geraldine was appointed to the Board as a Director in early 2010. She is a barrister of more than 30 years, with a particular experience in health law.

Lisa Keenan

Bachelor of Commerce, Chartered Management Accountant and Post Graduate Diploma of Applied Finance
Director

Lisa Keenan was elected as a Director of the ALLG in October 2020.

Malcolm McComas

BEc, LLB, SF Fin, FAICD
Director

Malcolm was elected to the Board, and has performed the role of Chairman of the Finance and Audit Committee of the Board, since May 2010.

Colin Allen

MBA (John Hopkins University, USA)

Colin was elected to the ALLG Board as a Director in late 2022 with aims to utilise his skills, experience and networks; and champion donor-centric experiences to achieve the ALLG’s philanthropic goals that will progress the mission for better treatments.

Professor

Andrew Roberts

MBBS, PhD, FRACP, FRCPA
Director

Andrew has been a Director with the ALLG Board since 2010, and has served on several other not-for-profit boards.

Professor

Deborah White

PhD FFSc (RCPA)
Director

Deborah was elected to the Board in March 2023. She has been an active member of the ALLG since 2002. Deborah is the Precision Medicine Theme Co-Leader at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide, and Group Leader of the Acute Lymphoblastic Leukaemia Genomics and Functional Genomics Research Group (Australian Lead Centre).

Professor

Peter Browett

BMedSci, MBChB, FRACP, FRCPA
Director

Peter has been an active member of the Company since April 1997. He currently chairs the Safety and Data Monitoring Committee (SDMC).